Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin αVβ3

Biochemical Journal

Volumn 418, Issue 2, 2009, Pages 325-336

  Liu, Lei ^a   Craig, Andrew W ^a   Meldrum, Heather D ^a   Marcovina, Santica M ^b   Elliott, Bruce E ^a   Koschinsky, Marlys L ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apolipoprotein A; Endothelial cell; Integrin V 3; Kinase phosphorylation; Transforming growth factor ; Wound healing

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A; C-JUN N-TERMINAL KINASE; ELEVATED PLASMA; ENDOTHELIAL FUNCTION; EXTRACELLULAR SIGNAL-REGULATED KINASE; FOCAL ADHESION KINASE; INTEGRIN; KINASE PHOSPHORYLATION; LYSINE-BINDING SITES; MITOGEN ACTIVATED PROTEIN KINASE; RISK FACTORS; TANDEM REPEATS; TRANSFORMING GROWTH FACTORS; VASCULAR ENDOTHELIAL CELL GROWTHS; WOUND HEALING;

AMINO ACIDS; BINDING ENERGY; BINDING SITES; BIOACTIVITY; BLOOD VESSEL PROSTHESES; CELL MEMBRANES; ENZYME ACTIVITY; GROWTH KINETICS; PEPTIDES; PHOSPHORYLATION; SELF ASSEMBLY;

ENDOTHELIAL CELLS;

APOLIPOPROTEIN A; FOCAL ADHESION KINASE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY LM 609; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN RECEPTOR; FOCAL ADHESION KINASE 2; RECOMBINANT PROTEIN;

ARTICLE; BINDING SITE; CELL ACTIVATION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; DELETION MUTANT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KRINGLE DOMAIN; MUTANT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTANT; VASCULAR ENDOTHELIUM; WOUND HEALING; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; ENDOTHELIUM CELL; ISOLATION AND PURIFICATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

APOPROTEIN(A); CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FOCAL ADHESION KINASE 2; HUMANS; INTEGRIN ALPHAVBETA3; LIPOPROTEINS, LDL; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 61449199538     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20080744     Document Type: Article

References (54)

1. Koschinsky, M. L. (2005) Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein. Curr. Atheroscler. Rep. 7, 389-395
2. McLean, J. W., Tomlinson, J. E., Kuang, W. J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M. and Lawn, R. M. (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330, 132-137
3. Eaton, D. L., Fless, G. M., Kohr, W. J., McLean, J. W., Xu, Q. T., Miller, C. G., Lawn, R. M. and Scanu, A. M. (1987) Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc. Natl. Acad. Sci. U.S.A. 84, 3224-3228
4. Koschinsky, M. L., Côté, G. P., Gabel, B. and van der Hoek, Y. Y. (1993) Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J. Biol. Chem. 268, 19819-19825
5. van der Hoek, Y. Y., Wittekoek, M. E., Beisiegel, U., Kastelein, J. J. and Koschinsky, M. L. (1993) The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum. Mol. Genet. 2, 361-366
6. Lackner, C., Cohen, J. C. and Hobbs, H. H. (1993) Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum. Mol. Genet. 2, 933-940
7. Harpel, P. C., Gordon, B. R. and Parker, T. S. (1989) Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc. Natl. Acad. Sci. U.S.A. 86, 3847-3851
8. Sangrar, W., Marcovina, S. M. and Koschinsky, M. L. (1994) Expression and characterization of apolipoprotein(a) kringle IV types 1, 2 and 10 in mammalian cells. Protein Eng. 7, 723-731
9. Gabel, B. R., May, L. F., Marcovina, S. M. and Koschinsky, M. L. (1996) Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation. Arterioscler. Thromb. Vasc. Biol. 16, 1559-1567
10. Becker, L., Cook, P. M., Wright, T. G. and Koschinsky, M. L. (2004) Quantitative evaluation of the contribution of weak lysine-binding sites present within apolipoprotein(a) kringle IV types 6-8 to lipoprotein(a) assembly. J. Biol. Chem. 279, 2679-2688
11. Belczewski, A. R., Ho, J., Taylor, Jr, F. B., Boffa, M. B., Jia, Z. and Koschinsky, M. L. (2005) Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10. Biochemistry 44, 555-564
12. Allen, S., Khan, S., Tam, S., Koschinsky, M., Taylor, P. and Yacoub, M. (1998) Expression of adhesion molecules by lp(a): a potential novel mechanism for its atherogenicity. FASEB J. 12, 1765-1776
13. Haque, N. S., Zhang, X., French, D. L., Li, J., Poon, M., Fallon, J. T., Gabel, B. R., Taubman, M. B., Koschinsky, M. and Harpel, P. C. (2000) CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 102, 786-792
14. Pellegrino, M., Furmaniak-Kazmierczak, E., LeBlanc, J. C., Cho, T., Cao, K., Marcovina, S.M., Boffa, M. B., Côté, G. P. and Koschinsky, M. L. (2004) The apolipoprotein(a) component of lipoprotein(a) stimulates actin stress fiber formation and loss of cell-cell contact in cultured endothelial cells. J. Biol. Chem. 279, 6526-6533
15. Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T. and De Bruijn, E. A. (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56, 549-580
16. Laurens, N., Koolwijk, P. and de Maat, M. P. (2006) Fibrin structure and wound healing. J. Thromb. Haemostasis 4, 932-939
17. Kim, J. S., Chang, J. H., Yu, H. K., Ahn, J. H., Yum, J. S., Lee, S. K., Jung, K. H., Park, D. H., Yoon, Y., Byun, S. M. and Chung, S. I. (2003) Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). J. Biol. Chem. 278, 29000-29008
18. Kim, J. S., Yu, H. K, Ahn, J. H., Lee, H. J., Hong, S. W., Jung, K. H., Chang, S. I., Hong, Y. K., Joe, Y. A., Byun, S. M. et al. (2004) Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases. Biochem. Biophys. Res. Commun. 313, 534-540
19. Yano, Y., Seishima, M., Tokoro, Y. and Noma, A. (1998) Stimulatory effects of lipoprotein(a) and low-density lipoprotein on human umbilical vein endothelial cell migration and proliferation are partially mediated by fibroblast growth factor-2. Biochim. Biophys. Acta 1393, 26-34
20. Koschinsky, M. L., Tomlinson, J. E., Zioncheck, T. F., Schwartz, K., Eaton, D. L. and Lawn, R. M. (1991) Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry 30, 5044-5051
21. Sangrar, W., Gabel, B. R., Boffa, M. B., Walker, J. B., Hancock, M. A., Marcovina, S. M., Horrevoets, A. J., Nesheim, M. E. and Koschinsky, M. L. (1997) The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface. Biochemistry 36, 10353-10363
22. Hancock, M. A., Boffa, M. B., Marcovina, S. M., Nesheim, M. E. and Koschinsky, M. L. (2003) Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces. J. Biol. Chem. 278, 23260-23269
23. McCance, S. G., Menhart, N. and Castellino, F. J. (1994) Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with omega-amino acid ligands. J. Biol. Chem. 269, 32405-32410
24. Edelstein, C., Hinman, J., Marcovina, S. and Scanu, A. M. (2001) Properties of human free apolipoprotein(a) and lipoprotein(a) after either freezing or lyophilization in the presence and absence of cryopreservatives. Anal. Biochem. 288, 201-208
25. Gabel, B. R., McLeod, R. S., Yao, Z. and Koschinsky, M. L. (1998) Sequences within the amino terminus of ApoB100 mediate its noncovalent association with apo(a). Arterioscler. Thromb. Vasc. Biol. 18, 1738-1744
26. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F. and Massague, J. (1992) TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014
27. Tarui, T., Miles, L. A. and Takada, Y. (2001) Specific interaction of angiostatin with integrin αvβ3 in endothelial cells. J. Biol. Chem. 276, 39562-39568
28. Elliott, B. E., Meens, J. A., SenGupta, S. K., Louvard, D. and Aprin, M. (2005) The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res. 7, R365-R373
29. Gautier, C., Levacher, C., Saez, J. M. and Habert, R. (1997) Expression and regulation of transforming growth factor β1 mRNA and protein in rat fetal testis in vitro. Biochem. Biophys. Res. Commun. 236, 135-139
30. Marcovina, S. M., Albers, J. J., Wijsman, E., Zhang, Z., Chapman, N. H. and Kennedy, H. (1996) Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J. Lipid Res. 37, 2569-2585
31. Blobe, G. C., Schiemann, W. P. and Lodish, H. F. (2000) Role of transforming growth factor-β in human disease. N. Engl. J. Med. 342, 1350-1358
32. Schaller, M. D. (2001) Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 1540, 1-21
33. Hanks, S. K., Ryzhova, L., Shin, N. Y. and Brabek, J. (2003) Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front. Biosci. 8, d982-d996
34. Mitra, S. K., Hanson, D. A. and Schlaepfer, D. D. (2005) Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell. Biol. 6, 56-68
35. Munoz-Chapuli, R., Quesada, A. R. and Medina, M. A. (2004) Angiogenesis and signal transduction in endothelial cells. Cell. Mol. Life Sci. 61, 2224-2243
36. Schulter, V., Koolwijk, P., Peters, E., Frank, S., Hrzenjak, A., Graier, W. F., van Hinsbergh, V. W. and Kostner, G. M. (2001) Impact of apolipoprotein(a) on in vitro angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 433-438
37. Tsukada, T., Eguchi, K., Migita, K., Kawabe, Y., Kawakami, A., Matsuoka, N., Takashima, H. and Mizokami, A. (1995) Transforming growth factor β1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem. Biophys. Res. Commun. 210, 1076-1082
38. Frater-Schroder, M., Muller, G., Birchmeier, W. and Bohlen, P. (1986) Transforming growth factor-β inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun. 137, 295-302
39. Muller, G., Behrens, J., Nussbaumer, U., Bohlen, P. and Birchmeier, W. (1987) Inhibitory action of transforming growth factor β on endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 84, 5600-5604
40. Heimark, R. L., Twardzik, D. R. and Schwartz, S. M. (1986) Inhibition of endothelial regeneration by type-β transforming growth factor from platelets. Science 233, 1078-1080
41. Petzelbauer, E., Springhorn, J. P., Tucker, A. M. and Madri, J. A. (1996) Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-β1. Am. J. Pathol. 149, 923-931
42. O'Neil, C. H., Boffa, M. B., Hancock, M. A., Pickering, J. G. and Koschinsky, M. L. (2004) Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-β activation and on the presence of kringle IV type 9. J. Biol. Chem. 279, 55187-55195
43. Becker, L., Webb, B. A., Chitayat, S., Nesheim, M. E. and Koschinsky, M. L. (2003) A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) formation. J. Biol. Chem. 278, 14074-14081
44. Becker, L., Cook, P. M. and Koschinsky, M. L. (2004) Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation. Biochemistry 43, 9978-9988
45. Weisel, J. W., Nagaswami, C., Woodhead, J. L., Higazi, A. A., Cain, W. J., Marcovina, S. M., Koschinsky, M. L., Cines, D. B. and Bdeir, K. (2001) The structure of lipoprotein(a) and ligand-induced conformational changes. Biochemistry 40, 10424-10435
46. Becker, L., McLeod, R. S., Marcovina, S. M., Yao, Z. and Koschinsky, M. L. (2001) Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a). J. Biol. Chem. 276, 36155-36162
47. Hynes, R. O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687
48. Mi, J., Zhang, X., Giangrande, P. H., McNamara, 2nd, J. O., Nimjee, S. M., Sarraf-Yazdi, S., Sullenger, B. A. and Clary, B. M. (2005) Targeted inhibition of αvβ3 integrin with an RNA aptamer impairs endothelial cell growth and survival. Biochem. Biophys. Res. Commun. 338, 956-963
49. Abbi, S. and Guan, J. L. (2002) Focal adhesion kinase: protein interactions and cellular functions. Histol. Histopathol. 17, 1163-1171
50. Guo, W. and Giancotti, F. G. (2004) Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816-826
51. Giancotti, F. G. and Ruoslahti, E. (1999) Integrin signaling. Science 285, 1028-1032
52. Ventura, J. J., Kennedy, N. J., Flavell, R. A. and Davis, R. J. (2004) JNK regulates autocrine expression of TGF-β1. Mol. Cell 15, 269-278
53. Roovers, K., Davey, G., Zhu, X., Bottazzi, M. E. and Assoian, R. K. (1999) α5β1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol. Biol. Cell 10, 3197-3204
54. Barre, D. E. (2007) Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor. Thromb. Res. 119, 601-607